Oncology Impact Fund L.P. Ubs's Net Worth

Oncology Impact Fund L.P. Ubs's net worth is estimated to be at least $4,940,941.40 as of 08/16/2022. CoreStreet's estimation of Oncology Impact Fund L.P. Ubs's net worth is based on their sale of stock and current holding of stock.

Oncology Impact Fund L.P. Ubs is Major Shareholder at Cullinan Oncology LLC. They have executed at least 11 trades of stock as per SEC Form 4 filings. Their most recent trade was for 6,425 units of CGEM stock on 09/15/2021. Their biggest sale was on 08/23/2021 when they sold 53,359 units of Cullinan Oncology LLC stock for $1,553,280.49. They typically trade 11 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $4,940,941.40
Most recent insider trade:
  • Sept. 15, 2021

Oncology Impact Fund L.P. Ubs's Insider Trading History

Cullinan Oncology LLCTitleAmountPriceTypeTotal Value
Sept. 15, 2021
Major Shareholder6,425$29.16Sell$187,353.00
Sept. 13, 2021
Major Shareholder3,595$29.10Sell$104,614.50
Sept. 9, 2021
Major Shareholder13,727$29.35Sell$402,887.45
Sept. 7, 2021
Major Shareholder25,067$29.04Sell$727,945.68
Sept. 3, 2021
Major Shareholder12,731$29.60Sell$376,837.60
Sept. 1, 2021
Major Shareholder5,714$29.47Sell$168,391.58
Aug. 30, 2021
Major Shareholder31,001$29.30Sell$908,329.30
Aug. 27, 2021
Major Shareholder13,357$29.09Sell$388,555.13
Aug. 25, 2021
Major Shareholder1,713$29.09Sell$49,831.17
Aug. 23, 2021
Major Shareholder53,359$29.11Sell$1,553,280.49
Aug. 11, 2021
Major Shareholder2,510$29.05Sell$72,915.50